Search Within

Paul Chapman

Formats
  1. Journal Article (206)
  2. Meeting Abstract (109)
  3. Book Section (8)
  4. Conference Paper (1)
  5. Editorial (1)
  6. Research Letter (1)
  7. Review (1)
Groups
  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (327)
  2. Department of Medicine (327)
  3. Melanoma and Immunotherapeutics Service (327)
  4. Solid Tumor Oncology Division (327)
  5. GSK Faculty (133)
  6. Melanoma Disease Management Team (93)

More Groups

People
  1. Jedd Wolchok (107)
  2. Katherine Panageas (77)
  3. Alan Houghton (60)
  4. Michael Postow (55)
  5. Margaret Callahan (50)
  6. Alexander Shoushtari (46)

More People

Years
  1. 2025 (1)
  2. 2024 (2)
  3. 2023 (8)
  4. 2022 (2)
  5. 2021 (9)
  6. 2020 (8)

More Years

Publications
  1. Journal of Clinical Oncology (88)
  2. Clinical Cancer Research (29)
  3. Cancer Research (15)
  4. Proceedings of the American Association for Cancer Research Annual Meeting (13)
  5. New England Journal of Medicine (11)
  6. Melanoma Research (10)

More Publications

Publishers
  1. American Society of Clinical Oncology (94)
  2. American Association for Cancer Research (60)
  3. Elsevier Inc. (22)
  4. Lippincott Williams & Wilkins (19)
  5. Wiley Blackwell (19)
  6. Oxford University Press (13)

More Publishers

Results (327)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Multigene sequencing, copy number alteration detection, and survival with first-line PD-1 based therapy in patients with mucosal melanoma
    Meeting Abstract

    Gottesdiener, L. S.; Gormally, M.; Armenia, J.; El-Jalby, M.; Postow, M. A.; Callahan, M. K.; Momtaz, P.; Wolchok, J. D.; Chapman, P. B.; Schultz, N.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Elevated levels of BRAF(V600) mutant circulating tumor DNA and circulating hepatocyte growth factor are associated with poor prognosis in patients with metastatic melanoma
    Journal Article

    Lu, W.; Burton, L.; Larkin, J.; Chapman, P. B.; Ascierto, P. A.; Ribas, A.; Robert, C.; Sosman, J. A.; McArthur, G. A.; Chang, I.; more...
    JCO Precision Oncology (2018)

    Fulltext@MSK | Save
  • Estimation of tumor-derived mutant allele fractions in cfDNA by shallow whole genome sequencing and fragment size analysis
    Meeting Abstract

    Yang, J.; Marass, F.; Ulz, P.; Shady, M.; Cheng, M. L.; Kothari, P.; Gedvilaite, E.; Somnay, S.; Shukla, N.; Modak, S.; more...
    Cancer Research (2018)

    Fulltext@MSK | Save
  • Intermittent treatment with MEK inhibitors in patients with oncogenic RAF-driven tumors: A potential strategy to manage toxicity and maintain efficacy
    Journal Article

    Yaeger, R.; Yao, Z.; Chapman, P. B.
    JCO Precision Oncology (2018)

    Fulltext@MSK | Save
  • Safety and clinical outcomes of ipilimumab and nivolumab plus concurrent stereotactic radiosurgery for brain metastases
    Meeting Abstract

    Johnson, C. B.; Postow, M. A.; Chapman, P.; Wolchok, J. D.; Brennan, C. W.; Tabar, V. S.; Chan, T. A.; Yamada, Y.; Yang, T. J.; Beal, K.
    International Journal of Radiation Oncology, Biology, Physics (2018)

    Fulltext@MSK | Save
  • Acetaminophen immediate release pharmacokinetics in iatrogenic overdose
    Meeting Abstract

    Yip, L.; Dart, R. C.; Spyker, D. A.; Chapman, P. B.
    Clinical Toxicology (2018)

    Fulltext@MSK | Save
  • Widespread selection for oncogenic mutant allele imbalance in cancer
    Journal Article

    Bielski, C. M.; Donoghue, M. T. A.; Gadiya, M.; Hanrahan, A. J.; Won, H. H.; Chang, M. T.; Jonsson, P.; Penson, A. V.; Gorelick, A.; Harris, C.; more...
    Cancer Cell (2018)

    Fulltext@MSK | Save
  • Outcomes of patients with metastatic melanoma selected for surgery after immunotherapy
    Meeting Abstract

    Bello, D. M.; Panageas, K. S.; Hollmann, T. J.; Shoushtari, A. N.; Chapman, P.; Postow, M. A.; Callahan, M. K.; Wolchok, J. D.; Brady, M. S.; Coit, D.; more...
    Annals of Surgical Oncology (2018)

    Fulltext@MSK | Save
  • Changing the standard of care for treating melanoma brain metastases
    Journal Article

    Chapman, P. B.
    Lancet Oncology (2018)

    Fulltext@MSK | Save
  • Selumetinib in combination with dacarbazine in patients with metastatic uveal melanoma: A phase III, multicenter, randomized trial (SUMIT)
    Journal Article

    Carvajal, R. D.; Piperno-Neumann, S.; Kapiteijn, E.; Chapman, P. B.; Frank, S.; Joshua, A. M.; Piulats, J. M.; Wolter, P.; Cocquyt, V.; Chmielowski, B.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save